article thumbnail

Value-Based Health Care Needs All Stakeholders at the Table – Especially the Patient

Health Populi

have struggled to pay for living expenses since December 2020, a year into the COVID-19 pandemic. To that point, consider the March 2021 Kaiser Family Foundation Health Tracking Poll which learned that over one in three people in the U.S.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

CMS may now enforce its COVID-19 vaccination policy for healthcare workers in all 50 states. HHS seeks $30B to combat COVID-19. As Alabama COVID numbers fall, ICUs across the state remained slammed. Doctors: Pediatric COVID cases appear to be trending down. Million in Covid Relief. CALIFORNIA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opill’s FDA Approval: Implications for Pharmaceutical Regulation and Access to Care

Bill of Health

SB: Both Medicaid and the Title X program go a long way to making contraceptives available, and these same issues have to be worked out by those programs. JRJ: Now, looking to the future of pharmaceutical regulation, the FDA approval of Opill is a significant milestone, from a legal or regulatory perspective.

FDA 184
article thumbnail

Health Provider News

Hall Render

health-tech startup MemoryWell pivots, eyes new funding to roll out software for insurers Department of Veterans Affairs health system kicks off multiyear Greater Washington expansion Georgetown to open Southeast D.C.

article thumbnail

Thinking Pharma on a Friday: Europe’s Big Reforms for a Health Union & the U.S. 50-State Fragments

Health Populi

The COVID-19 pandemic re-shaped European Union leaders to reimagine healthcare, public health, and health citizenship in the EU. On 26th April 2023, the EC unveiled the most significant reforms for the region’s pharmaceutical industry in twenty years. health citizen-consumers. The health plan assuring U.S.